Reducing surgical site infections (SSI) in breast surgeries, including a newly identified risk for sentinel node biopsies
نویسندگان
چکیده
منابع مشابه
Surgical-site infections and the NNIS SSI Risk Index: room for improvement.
Surveillance of surgical-site infections (SSI), with feedback of appropriate data to surgeons, has been shown to be an important component of strategies to reduce SSI risk. For SSIs, the traditional wound classification system, which stratifies each wound into one of four categories (clean, clean-contaminated, contaminated, and dirty-infected), has been available since 1964. Limitations of this...
متن کاملSentinel lymph node biopsy for risk-reducing mastectomy.
Risk-reducing mastectomy (RRM) confers 90-95% decreased risk of breast cancer, and may reduce mortality, especially in high-risk groups such as BRCA carriers. Risk of occult disease in RRM specimen is ~5%. This demands axillary staging: sentinel lymph node (SLN) biopsy is no longer possible, axillary clearance confers significant risks and may prove negative. Contemporaneous SLN biopsy allows a...
متن کاملTraps in Sentinel Lymph Node Biopsies
Sentinel lymph node biopsy has entered the mainstream of medical care for patients with breast cancer and melanoma. In most cases, the interpretation of the immunostains on sentinel lymph node biopsies is straightforward, although on occasion difficulties are encountered that can complicate interpretation. Knowledge of potential traps can be of assistance in attempts to render an accurate resul...
متن کاملLymphedema following breast cancer treatment, including sentinel lymph node biopsy.
To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience samp...
متن کاملReducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit?
Chlorhexidine gluconate (CHG) has been available as a topical antiseptic for over 50 years, having broad clinical application throughout the health care environment. Evidence-based clinical studies have shown chlorhexidine gluconate to be a safe and effective perioperative skin-prepping agent. Renewed interest has emerged for use of the antiseptic bath/shower to reduce the microbial skin burden...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Antimicrobial Resistance and Infection Control
سال: 2015
ISSN: 2047-2994
DOI: 10.1186/2047-2994-4-s1-o31